Jump to content

All Activity

This stream auto-updates

  1. Past hour
  2. aliumair

    We crossed the 500 mark

    Excellent post. I was always checking this blog, and I’m impressed! Extremely useful info specially the last part, I care for such information a lot. I was exploring this particular info for a long time. Thanks to this blog my exploration has ended. bmw777 login
  3. Tired of spending your evenings alone in Delhi's bustling surroundings? It's time to change that! Our agency is known for its reliability, discretion, and top-notch service. Our Delhi Escort service offers you a chance to meet some of the most beautiful and exciting women in the capital. Whether you're looking for a quick fling or a long, passionate night, our girls are ready to deliver. With 1500+ profiles to choose from, including college girls, models, and housewives, we have something for everyone. Book now and get free delivery within 30 minutes. Your perfect evening in Delhi starts here. Lutyens Escort || Escort in Maharani Bagh || Malviya Nagar Escort Service || Escort Service Bengali Market || Escort Service in Mandi House ||
  4. dario.neeko

    Test Blog entry

    Some truly wonderful work on behalf of the owner of this internet site , perfectly great articles . bmw777
  5. The following is the perfect posting I actually found as a consequence of promote them. It's really just what exactly Needed to check out anticipation around long run you are going to continue on to get spreading this sort of great posting. AK 게임
  6. Today
  7. divyarawat

    What Do Abortion and Cannabis Have in Common?

    With eight years of experience in the industry and more than 10,000 happy clients, we differentiate ourselves from other escort agencies in Delhi. Your satisfaction is our priority, letting you express your wishes for a personalized escort service experience in Delhi. Escorts in Chhatarpur || Civil Lines Escorts Service || Escorts Service Connaught Place || Escorts Service in Defence Colony || Pamposh Enclave Escorts
  8. AMA’s new marijuana stances; Congressional psychedelics bill; NH gov candidates clash on cannabis; MO marijuana workers unionize Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Hold on, just one second before you read today’s news. Have you thought about giving some financial support to Marijuana Moment? If so, today would be a great day to contribute. We’re planning our reporting for the coming months and it would really help to know what kind of support we can count on. Check us out on Patreon and sign up to give $25/month today: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Rep. Abe Hamadeh (R-AZ) and bipartisan cosponsors filed a bill to require the Department of Defense to evaluate how ongoing research on the therapeutic benefits of psilocybin could help members of the military. New Hampshire Democratic gubernatorial candidate Cinde Warmington is criticizing Gov. Kelly Ayotte’s (R) veto of a bill to allow medical cannabis companies to cultivate in greenhouses—saying it would have “made medical cannabis more affordable and more accessible to Granite Staters who really need it.” The American Medical Association’s House of Delegates adopted resolutions recognizing the therapeutic benefits and risks of marijuana use for older people and advocating a ban on flavored cannabis vapes. The American Bankers Association sent a letter urging congressional leaders to pass a marijuana banking bill—which it said is a more urgent need in light of developments surrounding the definition of legal hemp and the federal rescheduling of medical cannabis. “As a result, the volume of marijuana-related products and state-licensed proceeds is likely to increase substantially, exacerbating potential public safety and illicit finance risks.” Workers at more Missouri marijuana businesses are winning fights to unionize following a precedent-setting ruling by the National Labor Relations Board. / FEDERAL Rep. Steve Cohen (D-TN) authored an op-ed about federal marijuana rescheduling. / STATES Illinois’s lieutenant governor spoke about how social equity is central to the state’s cannabis legalization policy. A Virginia senator spoke about his opposition to the state’s new marijuana resentencing law. California regulators are accepting comments on proposed changes to rules for the cannabis appellations program. Michigan regulators published guidance about regulatory assessments for marijuana businesses. Hawaii regulators are launching a new medical cannabis patient registration site next month. Missouri regulators will soon accept applications to serve on the Cannabis Regulation Collaborative. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL Los Angeles, California officials sent a monthly cannabis newsletter. / INTERNATIONAL Thai Prime Minister Anutin Charnvirakul said the nation needs to reevaluate its marijuana laws to “prevent other countries from blaming Thailand as being the weak link in this problem.” Ghana’s education minister said students who sell marijuana should be dismissed from school. / SCIENCE & HEALTH A study found that “oral CBD may reduce blood pressure amongst healthy and hypertensive individuals, particularly under stressful conditions and during sleep.” A study suggested that “cannabis can serve as a short-term coping strategy for anxiety in young adults, leading to perceived emotional regulation.” / BUSINESS Auxly Cannabis Group Inc. shareholders elected board of directors members. / CULTURE Conan O’Brien again discussed his apprehension about using cannabis gummies. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Banking group pushes Congress to pass cannabis bill (Newsletter: July 7, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net
  9. dario.neeko

    Birth Behind Bars: Let’s Support This Canna Mom!

    This blog is so nice to me. I will keep on coming here again and again. Visit my link as well.. alexistogel
  10. This is such a great resource that you are providing and you give it away for free. I love seeing blog that understand the value of providing a quality resource for free. alexistogel login
  11. Honestly, Wacky Steps is the standout, but all the other games are genuinely fun too. Crazy Flips 3D is thrilling in its own way, Robber Run keeps my heart racing, Ragdoll Fight makes me laugh just as much as Wacky Steps, Getaway Shootout delivers endless chaos, and Mini-Caps: Bombs challenges my brain in a different way
  12. Yesterday
  13. A major banking organization is calling on Congress to pass legislation to ease marijuana businesses’ access to financial services. The Secure and Fair Enforcement (SAFE) Banking Act would “provide important legal and regulatory clarity” and “address a significant challenge facing American businesses, our communities, and the banks that serve them,” the American Bankers Association (ABA) wrote in a letter to House of Representatives and Senate leaders. Bipartisan lawmakers in both chambers of Congress refiled the cannabis banking legislation last month—the latest development in a long-term push for the reform, which has been approved by the House several times and advanced through a Senate committee, but has yet to be enacted into law. “Although nearly every U.S. state has legalized marijuana in some form, the uncertain legal landscape governing the proceeds of these state-licensed businesses means these businesses frequently operate on a cash basis, outside the regulated banking system,” ABA’s new letter says. “These state-legal proceeds also flow to non-cannabis businesses and service providers, including accountants, skilled trades, landlords, and law firms. “The SAFE Banking Act would remove barriers to banking these funds, materially reducing the amount of cash moving through state-licensed cannabis businesses and service providers,” the group wrote. “That, in turn, would reduce the risk that these businesses are targeted by bad actors, thereby improving public safety in the communities where they operate.” Developments surrounding the legal definition of hemp and the federal rescheduling of medical marijuana “underscore the need for Congress to act” on the issue, ABA said. “As a result, the volume of marijuana-related products and state-licensed proceeds is likely to increase substantially, exacerbating potential public safety and illicit finance risks,” the letter says. “SAFE Banking would provide needed certainty by allowing these funds to enter—or remain in—the regulated banking system.” “Passing this legislation would reduce illicit finance risk and increase financial transparency for cannabis- and hemp-derived proceeds. Highly regulated banks and other financial institutions must adhere to stringent anti-money laundering and counter-terrorist financing laws and rules, conduct due diligence regarding their customers, screen transactions for suspicious activity, and keep records. Bringing these state-licensed businesses and their proceeds into the formal financial system would provide a meaningful level of transparency and accountability by enabling financial institutions to better identify and report illicit finance risk.” The letter, which is addressed to House Speaker Mike Johnson (R-LA), Senate Majority Leader John Thune (R-SD), Senate Minority Leader Chuck Schumer (D-NY) and House Minority Leader Hakeem Jeffries (D-NY), along with the chairs and ranking members of the Senate Banking Committee and House Financial Services Committee, urges that the SAFE Banking Act receive “prompt consideration” by the panels and “timely passage by Congress.” The House passed versions of the SAFE Banking Act seven times, and the Senate Banking Committee approved a cannabis banking measure in 2023 but it was not subsequently taken up on the floor and died at the end of the 118th Congress. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Sen. Tim Scott (R-SC), who currently chairs the banking panel, said recently that the fact that marijuana remains illegal at the federal level while more states legalize it has created a “quandary” for cannabis businesses and banks that wish to serve them. Even though Scott has opposed the cannabis banking reform in the past, he said that the bill would “allow for the banking question to be solved by making it legal to bank it,” Scott said. “What you don’t want is to have a situation where you have these cash rooms where you have hundreds of thousands of dollars cash sitting in a location. Everyone knows you can’t bank it and therefore the criminal activity is much higher in these places.” The post Major Banking Group Pushes Congress To Pass Bill Easing Marijuana Businesses’ Access To Financial Services appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net
  14. “They basically thought it was impossible when all these companies were fighting, and now the workers are winning.” By Rebecca Rivas, Missouri Independent Missouri cannabis workers are trying to turn a string of recent union victories into broader organizing momentum across the state. High Profile Cannabis dispensary workers in Columbia last week unanimously ratified what union officials say is the state’s first collective bargaining contract for cannabis workers, securing higher pay and paid vacation time. “Now for the first time in Missouri, dispensary workers are FEELING THAT CONTRACT HIGH!” the United Food and Commercial Workers International Local 655 posted on its Facebook page Wednesday. And in St. Louis, Proper Brands post-harvest workers—who process and manufacture products—won their election to unionize last week, and Vibe Cannabis post-harvest workers are scheduled to hold an election at the end of July. “I’ve been hearing from more and more production and dispensary workers all over the state who want to find out what they need to do in order to organize their workplaces,” said Sean Shannon, organizing director at UFCW Local 655. “They basically thought it was impossible when all these companies were fighting, and now the workers are winning.” After Missouri legalized recreational marijuana in 2023, the state saw a surge in cannabis jobs that was soon followed by a push to unionize. Several groups of workers endured yearslong legal battles and company pushback. This year, some are finally seeing the results. Sierra Lutz was among the employees who organized the High-Profile union petition in 2023. She’s now a trimming tech at Vibe Cannabis, where she is leading the unionization campaign. She and her fellow post-harvest workers filed a petition to unionize last month. After hearing the news about High Profile’s contract, Lutz applauded the workers’ dedication. “I’m so proud of their perseverance,” she said. “They deserve every second of this glory.” Her work with High Profile taught her some key lessons she’s bringing to the Vibe campaign, she said. The main one: “patience is everything.” “The workplace won’t change overnight, but change will come,” Lutz said. “That’s been my biggest point I’ve been communicating to Vibe employees.” Other Vibe employees are also organizing veterans, after participating in the unionization effort at BeLeaf Medical’s Sinse cultivation facility in St. Louis. In May, Sinse workers won a significant legal precedent for post-harvest workers after nearly three-year battle, with a decision affirming their right to unionize under federal labor law. “More and more workers are feeling empowered,” Shannon said, “and I believe we’re going to see a huge wave and a rise in workers rising together.” ‘A seat at the table’ Katie Hazelwonder, a trainer in Proper’s post-harvest department, said she was overjoyed that workers voted 25-21 to unionize on July 1. “We put a lot of work into this, and I’m so thankful to everyone that stood together to make this happen,” Hazelwonder said. “That’s honestly the only way we got through this, we stood together and never backed down.” Hazelwonder acknowledged this was a stressful month for “both sides of the vote,” but said she believes the effort will result in better pay, job security and working conditions. “This victory is about all of us having a voice and having a seat at the table,” she said, “and we’re looking forward to negotiating a fair contract that reflects the hard work and dedication of everyone.” John Pennington, founder and CEO of Proper Brands, said in an email to The Independent that the company respects the post-harvest team’s decision and their right to determine how they want to be represented. “Proper Brands has always believed that our people are the foundation of our success, and that commitment remains unchanged,” Pennington said. “As we move forward, our focus will be on building a constructive relationship rooted in mutual respect, open communication, and our shared goal of producing the highest-quality cannabis products for Missouri.” Pennington also said the company remains committed to “providing a safe, supportive workplace where every team member has the opportunity to grow and contribute to our continued success.” “We are pleased to be a part of this process,” he said, “and look forward to working with the UFCW.” Hazelwonder previously told The Independent that the Proper team was encouraged by a May decision from the National Labor Relations Board, which decides labor disputes and sets national policy on union organizing. The board rejected another St. Louis marijuana company’s argument that post-harvest employees are agricultural workers, who are excluded from a federal law that protects most private-sector employees’ right to unionize without fear of retaliation. “Thanks to the recent NLRB ruling we have the opportunity to sit at the table and make it better for us and the others to come,” Hazelwonder said. Vibe At Vibe, Lutz said she and other production workers were told they’d have the federal Juneteenth holiday off this year. But then a few days before the holiday, she says managers told them they would have to work. They later learned the company paid for another department’s employees to go to Six Flags theme park on Juneteenth. It’s part of the favoritism, such as free meals and other perks, her team doesn’t get to enjoy. “I love that that department gets all of that extra stuff, like, genuinely,” Lutz said, “but our department gets absolutely nothing.” Juneteenth was the last straw for post-harvest employees who were on the fence about unionizing, Lutz said, and Shannon filed the petition to unionize on June 18. Katie Parker, human resources manager for Vibe, said the company had no comment on the petition or the issues raised by employees. Since the petition was filed, Lutz said workers have been required to meet individually with two consultants, who told employees the company hired them to educate workers on the union process. Lutz works in the trim department, where she operates the Mobius trimming machine, she said. During the summer, she said, the room is often 80 degrees with poor air circulation. “They’ve told us many times that the thing that they are worried about getting above 80 degrees in that room is not our wellbeing as employees,” she said, “but the wellbeing of the product.” She said she and her colleagues do challenging work that’s vital to the quality ofVibe’s product, but they don’t see the pay raises other departments do. Bird Herndon, who has worked in Vibe’s post-harvest department for about a year, agreed with Lutz. “Cannabis cultivation and processing are physically demanding and almost always impact respiratory health,” Herndon said. “Making sure we have consistent access to safety equipment like respirators is a top priority.” Herndon said a structured collective bargaining process would allow the team to “work collaboratively with management to formalize, streamline, and uphold high-standard safety procedures and equipment protocols for everyone.” Among the group’s demands is the option of a 401(k) so they can plan for retirement. Vibe employees have been in touch with organizers at Proper and BeLeaf, Herndon said, to learn from their experiences. “We can all help each other,” Herndon said. “More minds on the problem leads to a better solution for everyone.” This story was first published by Missouri Independent. Photo courtesy of Chris Wallis // Side Pocket Images. The post Workers At More Missouri Marijuana Businesses Win Union Fights Following Federal Ruling appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net
  15. The American Medical Association (AMA) has adopted two new marijuana-related resolutions—one that advocates for a ban on flavored cannabis vaping products and another that recognizes the risks and potential therapeutic benefits of use among older adults. AMA’s House of Delegates last month approved both measures—the latest in a line of drug policy-related resolutions the body has advanced in recent years that oppose commercial marijuana legalization while backing expungement of cannabis records and supporting broad drug decriminalization, among stances on other issues. The newly adopted measure on marijuana use by older people simultaneously notes that there is a “higher incidence of dementia among individuals who use cannabis” but also that “cannabis may offer therapeutic benefits for managing agitation in dementia patients, potentially serving as an alternative to antipsychotic medications.” “Greater transparency regarding both the potential benefits and adverse effects of cannabis use in older adults would be valuable to physicians, particularly given the current paucity of research that is focused on this population,” it says. As such the measure maintains that: “RESOLVED, that our American Medical Association support the development and publication of educational resources on medical cannabis directed towards clinicians, including a virtual educational presentation that reviews the known effects of medical cannabis in older adults that highlights both its potential benefits and risks; and be it further RESOLVED, that our AMA encourage expanded research into the therapeutic uses of cannabis in older adults—such as for managing agitation in individuals with cognitive impairment—as well as its possible adverse effects.” The separate AMA-approved measure on flavored cannabis vapes argues that cannabis can have a “strong, earthy, or even bitter taste” that some users find “unpalatable” and that flavored cartridges can “mask the unpleasant taste of cannabis”—which it says have “increased adolescents’ willingness to try them.” As such, the resolution concludes that: “RESOLVED, that our American Medical Association advocate and support a complete ban on the production, marketing, and sale of Cannabis based ECIG flavored devices and cartridges throughout all regulated cannabis dispensaries (medical and adult-use) along with any outlet selling hemp products and public health entities; and be it further RESOLVED, that our AMA pursue legislative changes concerning a comprehensive ban on the production, marketing and sale of cannabis-based ECIG flavored devices and cartridges in the United States.” The newly adopted resolutions build on AMA’s existing policies taking stances on various cannabis and drug policy issues. In 2024, for example, AMA delegates adopted a resolution endorsing broad drug decriminalization. The group’s delegates in 2022 voted to amend its policy position on marijuana—which continues to oppose legalization—to support the expungement of past cannabis convictions in states that have legalized the plant. In 2023, AMA members adopted resolutions advocating for psychedelics research, opposing the criminalization of kratom, calling for an end to the sentencing disparity between crack and powder cocaine and supporting the continued inclusion of marijuana metabolites in employment-based drug tests. The post AMA Says Marijuana Has Benefits And Risks For Older Adults, While Supporting A Ban On Flavored Cannabis Vapes appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net
  16. This particular is usually apparently essential and moreover outstanding truth along with for sure fair-minded and moreover admittedly useful My business is looking to find in advance designed for this specific useful stuffs… new construction homes in ave maria fl
  17. aliumair

    We crossed the 500 mark

    Took me time to read all the comments, but I really enjoyed the article. It proved to be Very helpful to me and I am sure to all the commenters here! It’s always nice when you can not only be informed, but also entertained! top realtor in ave maria fl
  18. A bipartisan group of lawmakers have filed a new bill in Congress what would require the Department of Defense to evaluate how ongoing research on the therapeutic benefits of psilocybin could help members of the military. The Veterans and Servicemembers PTSD Emerging Treatment Review Act, filed this week by Rep. Abe Hamadeh (R-AZ), would direct the assistant secretary of defense for health affairs to coordinate with other federal officials to issue a report on how the results of study on psychedelic mushrooms that is currently being carried out in Arizona could “apply to members of the Armed Forces, including such members transitioning to civilian life.” The report, due within 180 days of the legislation being enacted, would need to include “a summary of the safety, dosing, and adverse event data” from the research as well as “an assessment of the implications of such data for force health protection, medical readiness, and suicide prevention strategies.” Officials would also need to describe “legal and regulatory requirements for any potential expanded access pathway involving an investigational Schedule I substance” and provide an assessment of the applicability of the federal Right to Try law and a psychedelics executive order signed by President Donald Trump for treating PTSD during post-deployment and transition periods. The bill, which is cosponsored by Reps. Don Bacon (R-NE), Dan Crenshaw (R-TX) and Seth Moulton (D-MA), also contains a findings section that points out that existing PTSD therapies “are not effective for all patients.” “Rigorous, ethical clinical research conducted in accordance with Federal law and force health protection standards is necessary to evaluate emerging treatments for service-connected mental health conditions where existing therapies have proven insufficient,” it says. “Private-sector innovators and public-private partnerships play a central role in developing, supplying, and evaluating federally lawful investigational products used in such clinical trials.” The legislation also notes that psychedelic research underway in Arizona is “evaluating naturally derived, whole-mushroom psilocybin administered within a structured group-therapy setting for the treatment of post-traumatic stress disorder in veterans and first responders.” Hamadeh said in a press release about the new bill that “our servicemembers and veterans deserve every opportunity to access the most effective treatments backed by rigorous scientific research.” “Far too many Americans continue to struggle with treatment-resistant PTSD, contributing to suicide, substance abuse and challenges transitioning back to civilian life,” he said. “This legislation ensures Congress and the Department of Defense have the data needed to evaluate emerging research and make informed decisions that prioritize military readiness, force health and veteran care.” Sue Sisley, the researcher overseeing the Arizona-based psilocybin investigation, said Hamadeh’s staff visited her facility and “saw firsthand what these FDA clinical trials mean for veterans and first responders, and what it could mean for transitioning servicemembers in the future.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Last week week, bipartisan congressional lawmakers filed a separate bill they say is intended to codify Trump’s psychedelics executive order into law. Reps. Morgan Luttrell (R-TX), Lou Correa (D-CA), Jack Bergman (R-MI) and Michael McCaul (R-TX) introduced the Initiating Biomedical Outcomes to Garner Advancements into Innovative Neuroplastogen Efficacy (IBOGAINE) Act on Tuesday. The legislation would direct the attorney general to “take all necessary steps to determine whether to transfer ibogaine and ibogaine compounds” from schedule I to schedule II of the Controlled Substances Act (CSA) within 60 days. It also says that the attorney general and the health and human services secretary would need to initiate proceedings to reschedule any other Schedule I substances that complete Phase 3 clinical trials. It would create a definition under federal law for ibogaine, to include “all parts of the plant Tabernanthe iboga” as well as any similar compound or analog that “acts on neuroplasticity, opioid receptors, or serotonergic pathways” that interrupt addiction cycles and restore neurological function disrupted by trauma, chronic substance use or traumatic brain injury. It would further codify a national priority voucher program to support development of psychedelic and other therapies that can treat widespread maladies. The legislation would additionally clarify that the federal Right to Try law provides exemptions from the CSA for seriously ill patients to access psychedelics and other Schedule I drugs in accordance with new special registration requirements it would create. The Drug Enforcement Administration (DEA) would also have to revise its quotas for the amount of a controlled substance that can be legally produced if it is rescheduled, approved by the Food and Drug Administration (FDA) or designated as a breakthrough therapy. The bill also creates a process for federal agencies to partner with states to “advance research on, and development of, psychedelic drugs, including ibogaine, for treating serious mental illnesses” as well as a framework for health agencies and the Department of Veterans Affairs (VA) to “collaborate with the private sector to increase clinical trial participation, data sharing, and real-world evidence generation regarding psychedelic drugs.” Luttrell and some of the cosponsors of the bill are also behind a proposed amendment to the National Defense Authorization Act that would extend a psychedelics research effort at the Department of Defense (DOD) for an additional six years. That proposal was cleared this week for floor action by the House Rules Committee. Shortly after Trump signed the executive order, FDA and the Department of Health and Human Services (HHS) announced steps that they say will help with “accelerating” therapeutic access to psychedelics for patients dealing with serious mental health conditions. Health and Human Services Secretary Robert F. Kennedy Jr. said recently that the Trump administration is “very anxious” to create a pathway for access to psychedelics therapy and that top officials across federal agencies want to “get it out to the public as quickly as possible.” In an interview on the Joe Rogan Experience in February, Kennedy said he’s confident “we’re going to get it done,” with plans to develop and finalize rules that would enable patients with conditions such as post-traumatic stress disorder (PTSD) and depression to access psychedelic substances like psilocybin and MDMA in a “very controlled setting.” “Everybody in my agency…is very anxious to get a rule out there that will allow these kind of studies and will allow access under therapeutic settings, particularly [for] the military soldiers who have suffered these injuries to get access to these products,” the HHS secretary said. “We’re working through that process now. We’re all working on it and trying to make it happen.” “I think that we’re going to get it done,” he said. Last June, Kennedy said his agency is “absolutely committed” to expanding research on the benefits of psychedelic therapy and, alongside of the head of FDA, is aiming to provide legal access to such substances for military veterans “within 12 months.” Veterans Affairs Secretary Doug Collins also disclosed in April that he had an “eye-opening” talk with Kennedy about the therapeutic potential of psychedelic medicine. And he said he’s open to the idea of having the government provide vouchers to cover the costs of psychedelic therapy for veterans who receive services outside of VA as Congress considers pathways for access. Bipartisan congressional lawmakers introduced legislation this session to provide $30 million in funding annually to establish psychedelic-focused “centers for excellence” at U.S. Department of Veterans Affairs (VA) facilities, where veterans could receive novel treatment involving substances like psilocybin, MDMA and ibogaine. A U.S. Senate committee held a hearing in April on a bipartisan bill to promote research into the therapeutic potential psychedelics by creating a new office at VA that would advance the development innovative treatments for serious mental health conditions and assist in reviewing the scheduling status of drugs like psilocybin, ibogaine and MDMA. Read the full psilocybin bill below: The post Defense Department Would Issue Report On How Psychedelic Mushrooms Can Benefit Military Members Under New Congressional Bill appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net
  19. A New Hampshire Democratic gubernatorial candidate is criticizing the incumbent Republican governor for vetoing a bill to let medical cannabis companies grow marijuana in greenhouses. Supporters say the proposal will make cannabis more affordable and available for patients, and it passed the Senate and House of Representatives in voice votes this session—but Gov. Kelly Ayotte (R) vetoed it last month. “Come on, Kelly. Shouldn’t we be trying to make health care more affordable for Granite Staters, not less?” Cinde Warmington, the sole Democrat running for her party’s nomination to challenge Ayotte in November, said in a video posted to social media. “This bill would have made medical cannabis more affordable and more accessible to Granite Staters who really need it, and she vetoed it,” Warmington said. “But honestly, this is what we’ve come to expect from Kelly Ayotte. Look what she did to the Medicaid premiums. She increased them by up to $270 a month on the most vulnerable Granite Staters. She increased prescription co-pays when other costs are already going through the roof.” “New Hampshire deserves a governor who will fight to make sure we have lower health care costs and that health care is more accessible,” the Democratic candidate, who previously served as a member of the New Hampshire Executive Council, said. “That’s the bottom line.” Making medical cannabis more expensive for Granite Staters? Come on, Kelly. #NHPolitics pic.twitter.com/OWfoQspFQi — Cinde Warmington (@CindeWarmington) June 24, 2026 In a veto statement on the medical marijuana greenhouse bill, the governor simply said, “I do not support expanding the cultivation of marijuana in our state.” Meanwhile, New Hampshire lawmakers and advocates are pushing to override Ayotte’s veto. “I disagree with the governor’s decision to veto SB 468,” Sen. Howard Pearl (R), the lead sponsor of the legislation, told Marijuana Moment last month. “This bipartisan bill would have provided a practical way to lower costs for patients with serious medical conditions while maintaining the rigorous oversight and safeguards that have made New Hampshire’s Therapeutic Cannabis Program successful.” “At a time when affordability remains a significant challenge for many families, we should be looking for responsible ways to expand access to treatment and ease financial burdens,” he said. Sen. Tara Reardon (D) similarly said she is “disappointed” in the governor’s action, which she said will result in “denying cost-saving measures for more than 17,000 veterans and patients across New Hampshire who rely on medical cannabis as an important component of their physician-recommended care.” “I hope my Senate colleagues will join me in voting to override the veto and pass the bill into law,” she told Marijuana Moment. The legislation says that “each alternative treatment center registered under this section may request authorization to operate a greenhouse cultivation location, at the same or at a different location than its existing cultivation location, in order to reduce energy costs and provide lower prices for registered qualifying patients.” The only person to testify against the bill this session was a former state lawmaker who now serves as chair of the prohibitionist organization Smart Approaches to Marijuana NH. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Ayotte has separately threatened to veto any marijuana legalization bill that reaches her desk. The governor said last year that her position on the reform would not change even as the federal government moved forward with rescheduling the plant. In 2024, then-Gov. Chris Sununu (R) vetoed a similar proposal to allow cannabis businesses to cultivate in greenhouses. The House had enough votes to override that action, but the Senate did not. Photo courtesy of Chris Wallis // Side Pocket Images. The post New Hampshire Democratic Challenger Slams GOP Governor’s Veto Of Medical Marijuana Greenhouse Cultivation Bill appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net
  20. Awesome article! I want people to know just how good this information is in your article. It’s interesting, compelling content. Your views are much like my own concerning this subject. 인디고 게임
  21. aliumair

    The Truth About Women in Cannabis

    her in fact awesome blog page. her realy content rich and then a this fantastic profession. i prefer this unique. bandar togel
  22. Succeed! It could be one of the most useful blogs we have ever come across on the subject. Excellent info! I’m also an expert in this topic so I can understand your effort very well. Thanks for the huge help. 성인피시 This blog website is pretty cool! How was it made ! 성인피시
  23. jackbacha

    Pass it Forward

    This is a great post. I like this topic.This site has lots of advantage.I found many interesting things from this site. It helps me in many ways.Thanks for posting this again. 온라인바둑이
  24. It was extremely all around composed and straightforward. Not at all like different online journals I have perused which are truly not that good.Thanks a lot white blanket box
  25. dario.neeko

    The Biz Buzz: Sway Blunts

    Great survey, I'm sure you're getting a great response. alexistogel daftar
  26. ID medical marijuana signatures; Trucking groups’ rescheduling warning; Cayman Islands cannabis report; TN legalization push; NC hemp restrictions Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen. If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW An Idaho medical cannabis campaign submitted county-verified signatures for its legalization ballot measure for final review by the secretary of state’s office—though it didn’t specify whether the county-level review indicated they collected enough valid petitions. The American Trucking Associations and other transportation and safety groups sent a letter telling federal officials they have “serious safety concerns” about the Trump administration’s cannabis rescheduling move—requesting they take steps to “preserve employers’ ability to test safety‑sensitive transportation workers for marijuana.” The Cayman Islands Law Reform Commission published a report on options for marijuana reform following voters’ approval of a referendum supporting cannabis decriminalization. The Drug Policy Alliance’s Cat Packer details in a new Marijuana Moment op-ed what it was like inside the first days of the Drug Enforcement Administration’s cannabis rescheduling hearing—saying it “matters—but it fails to consider or address the biggest questions facing marijuana reform.” “There was no discussion of the lasting harms of marijuana criminalization itself—the arrests, convictions, incarceration and collateral consequences that continue to affect individuals, families and communities.” The North Carolina Senate passed a bill to restrict hemp and kratom products—going further than the House of Representatives, which voted to limit sales of hemp THC products to people over the age of 21 but not ban them. Tennessee Democratic lawmakers are stepping up the push to legalize marijuana with a bill called the Pot for Potholes Act as new restrictions on hemp THC products take effect in the state. Georgia’s newly expanded medical cannabis law could triple the number of registered patients in the program within a year, according to the CEO of one of the state’s licensed medical marijuana companies. Virginia hemp farmers and retailers are worried that changes to rules for products derived from the crop that were included in newly passed legislation to legalize recreational marijuana sales will devastate their businesses. / FEDERAL Army Secretary Dan Driscoll issued a memo banning use of kratom and related products for servicemembers. Sen. Raphael Warnock (D-GA) pointed out that some people are “locked up” on nonviolent marijuana and drug charges yet “other people are now millionaires because of cannabis.” / STATES A spokesperson for New Mexico Gov. Michelle Lujan Grisham (D) pushed back against criticism that a new policy requiring officials to seek immediate custody of newborns found to be exposed to drugs will “flag alcohol or marijuana use before” women are pregnant. California regulators announced a recall of marijuana products due to pesticide contamination. Oklahoma regulators adopted changes to medical cannabis rules. Illinois regulators published guidance on changes to hemp rules. Colorado Legislative Council Staff published a report on marijuana legislation enacted this session. Virginia regulators published an overview of changes to cannabis laws that were enacted this session. Oregon regulators are accepting applications to serve on a cannabis and psilocybin testing rules advisory committee. New Jersey regulators published information about cannabis use and pregnancy. The Massachusetts Cannabis Control Commission will meet on July 30. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL Denver, Colorado officials published a marijuana social equity report. / INTERNATIONAL The Philippine Supreme Court is being asked to declare the country’s bloody “war on drugs” unconstitutional. / SCIENCE & HEALTH A review concluded that “cannabinoid-based therapies showed lower agitation and neuropsychiatric symptom scores than placebo in” Alzheimer’s disease. A study found that “supervised use of full-spectrum medical Cannabis oil was associated with favorable patient-reported perceptions of quality of life and sleep.” / BUSINESS Terra Herbal Health LLC is suing the Internal Revenue Service to challenge 280E tax deficiencies and penalties in light of cannabis rescheduling. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Chris Wallis // Side Pocket Images. The post Inside DEA’s cannabis rescheduling hearing (Newsletter: July 6, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net
  27. Thanks for the blog loaded with so many information. Stopping by your blog helped me to get what I was looking for. apollo group tv login
  28. I am impressed. I don't think Ive met anyone who knows as much about this subject as you do. You are truly well informed and very intelligent. You wrote something that people could understand and made the subject intriguing for everyone. Really, great blog you have got here. บอลสูงต่ำวันนี้
  1. Load more activity
×
×
  • Create New...